CN103830697B - A kind of pharmaceutical composition for the treatment of postpartum retention of urine - Google Patents
A kind of pharmaceutical composition for the treatment of postpartum retention of urine Download PDFInfo
- Publication number
- CN103830697B CN103830697B CN201410070799.1A CN201410070799A CN103830697B CN 103830697 B CN103830697 B CN 103830697B CN 201410070799 A CN201410070799 A CN 201410070799A CN 103830697 B CN103830697 B CN 103830697B
- Authority
- CN
- China
- Prior art keywords
- pharmaceutical composition
- urine
- treatment
- postpartum retention
- retention
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000008194 pharmaceutical composition Substances 0.000 title claims abstract description 25
- 206010046555 Urinary retention Diseases 0.000 title claims abstract description 23
- 239000000463 material Substances 0.000 claims abstract description 8
- 239000002994 raw material Substances 0.000 claims abstract description 8
- 239000003814 drug Substances 0.000 claims description 12
- 238000002360 preparation method Methods 0.000 claims description 6
- 238000003958 fumigation Methods 0.000 claims description 4
- 229940040145 liniment Drugs 0.000 claims 1
- 239000000865 liniment Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 4
- 230000003236 psychic effect Effects 0.000 abstract 1
- 229940079593 drug Drugs 0.000 description 9
- 238000000034 method Methods 0.000 description 8
- 239000008187 granular material Substances 0.000 description 5
- 238000010298 pulverizing process Methods 0.000 description 5
- 210000002700 urine Anatomy 0.000 description 4
- 230000014759 maintenance of location Effects 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 2
- 241000607292 Maguireothamnus speciosus Species 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 208000018525 Postpartum Hemorrhage Diseases 0.000 description 2
- 238000001467 acupuncture Methods 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 206010013990 dysuria Diseases 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 241001673966 Magnolia officinalis Species 0.000 description 1
- 206010062519 Poor quality sleep Diseases 0.000 description 1
- 244000046101 Sophora japonica Species 0.000 description 1
- 235000010586 Sophora japonica Nutrition 0.000 description 1
- 208000036029 Uterine contractions during pregnancy Diseases 0.000 description 1
- 241000234314 Zingiber Species 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 230000035606 childbirth Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000007952 growth promoter Substances 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 238000013312 nursing technique Methods 0.000 description 1
- 230000036544 posture Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000009991 scouring Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
- A61K36/575—Magnolia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/744—Gardenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/746—Morinda
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a kind of pharmaceutical composition for the treatment of postpartum retention of urine, this pharmaceutical composition is prepared from by following traditional Chinese medicinal material raw materials by weight: Cortex Magnoliae Officinalis 23-30 part, Fructus Gardeniae 21-30 part, Fructus Sophorae 32-45 part, Rhizoma Zingiberis 6-10 part, Radix Morindae Officinalis 6-12 part.Pharmaceutical composition of the present invention is very remarkable for the curative effect of postpartum retention of urine patient, applies also simple and easy to do, reduces length of stay simultaneously, both relieved the psychic pain of patient, also mitigate the financial burden of patient.
Description
Technical field
The invention belongs to Chinese medicine nursing technique field, be specifically related to a kind of pharmaceutical composition for the treatment of postpartum retention of urine.
Background technology
Postpartum retention of urine is the common complication of obstetrics, incidence rate 7%-10%.Postpartum retention of urine refers to that 6-8h filling of bladder in puerperal can not Self-discharged urine, generation dysuria and row's urine retention.Puerperal once there is urine retention in puerpera, and full bladder compressing uterus, causes uterine contraction bad, occur postpartum hemorrhage.The hemorrhage anxiety of puerpera, impact feed and sleep, and poor sleep affects the secretion of breast amount, makes puerpera can not accomplish suckling as required, affects neonatal growth promoter; In addition, because dysuria in puerperal causes psychentonia, be easy to bring out mental disorder.So puerperal should empty bladder as early as possible, reduces the incidence rate of postpartum hemorrhage, increases comfort level in puerperal, promote postpartum recovery.
At present, the Therapeutic Method for puerpera's postpartum retention of urine comprises conventional induced uresis method, Catheterization, acupuncture method, finger pressure diuresis cave method.Conventional induced uresis method as hot compress, massage, listen the induction ratio juris such as the underwater sound to be by massage pushing, reaching reflexive stimulates detrusor of bladder to shrink to cause and urinate, but less effective, and has the possibility causing rupture of bladder; The danger that Catheterization causes suffering to puerpera and infects; The methods such as acupuncture and moxibustion therapy, finger pressure diuresis cave, comparatively bother and require efforts.
Summary of the invention
In view of the deficiencies in the prior art, the object of the present invention is to provide a kind of pharmaceutical composition for the treatment of postpartum retention of urine evident in efficacy.In order to realize object of the present invention, inventor continues research and explores on the basis of secret prescription handed down in the family from generation to generation, finally obtains following technical scheme:
Treat a pharmaceutical composition for postpartum retention of urine, by weight, described pharmaceutical composition is prepared from by following traditional Chinese medicinal material raw materials: Cortex Magnoliae Officinalis 23-30 part, Fructus Gardeniae 21-30 part, Fructus Sophorae 32-45 part, Rhizoma Zingiberis 6-10 part, Radix Morindae Officinalis 6-12 part.
Preferably, the pharmaceutical composition for the treatment of postpartum retention of urine as mentioned above, by weight, described pharmaceutical composition is prepared from by following traditional Chinese medicinal material raw materials: Cortex Magnoliae Officinalis 25-27 part, Fructus Gardeniae 24-26 part, Fructus Sophorae 36-40 part, Rhizoma Zingiberis 7-9 part, Radix Morindae Officinalis 8-10 part.
Further preferably, the pharmaceutical composition for the treatment of postpartum retention of urine as mentioned above, by weight, described pharmaceutical composition is prepared from by following traditional Chinese medicinal material raw materials: Cortex Magnoliae Officinalis 26 parts, Fructus Gardeniae 25 parts, the Fructus Sophorae 38 parts, Rhizoma Zingiberis 8 parts, Radix Morindae Officinalis 9 parts.
The pharmaceutical composition of fumigation in treating postpartum retention of urine of the present invention can be prepared into powder, and method is: take Cortex Magnoliae Officinalis 23-30 part, Fructus Gardeniae 21-30 part, Fructus Sophorae 32-45 part, Rhizoma Zingiberis 6-10 part and Radix Morindae Officinalis 6-12 part, cleans roguing, dry, be ground into granule, pulverization, subpackage.
Found by Multitest research and a large amount of clinical practice, pharmaceutical composition of the present invention is by the curative effect highly significant to puerpera's postpartum retention of urine after stifling scouring treatment.Therefore, second object of the present invention is to provide a kind of pharmaceutical applications, i.e. the application of aforementioned pharmaceutical compositions in the external used medicine of preparation treatment puerpera postpartum retention of urine.
Compared with prior art, pharmaceutical composition of the present invention adopts stifling mode of cleaning to be used for the treatment of postpartum retention of urine patient, and its curative effect is very remarkable, apply also simple and easy to do, can avoid will inserting urinary catheter because of urine retention, the danger causing suffering to puerpera and infect, more easily by patient is accepted; Reduce length of stay simultaneously, both relieved patient mental's misery, also mitigate the financial burden of patient.
Detailed description of the invention
It should be noted that, traditional Chinese medicinal material raw materials of the present invention has following source: Cortex Magnoliae Officinalis selects the dry dried bark of Magnoliacea plant Cortex Magnoliae Officinalis MagnoliaofficinalisRehd.etWils. or magnolia officinalis rehd.et wils.var.biloba rehd.et wils. MagnoliaofficinalisRehd.etWils.var.bilobaRehd.etWils., root bark and branch skin; Fructus Gardeniae selects the dry mature fruit of Maguireothamnus speciosus Fructus Gardeniae GardeniajasminoidesEllis; The Fructus Sophorae selects the dry mature fruit of leguminous plant Chinese scholartree SophorajaponicaL.; Rhizoma Zingiberis selects the dry rhizome of zingiber ZingiberofficinaleRosc.; Radix Morindae Officinalis selects the dry root of Maguireothamnus speciosus Radix Morindae Officinalis MorindaofficinalisHow.
Be below specific embodiments of the invention, technical scheme of the present invention is done to describing further, but protection scope of the present invention be not limited to these embodiments.Every do not deviate from the present invention's design change or equivalent substituting include within protection scope of the present invention.
embodiment 1
Crude drug prescription: Cortex Magnoliae Officinalis 0.26 kilogram, Fructus Gardeniae 0.25 kilogram, the Fructus Sophorae 0.38 kilogram, Rhizoma Zingiberis 0.08 kilogram, Radix Morindae Officinalis 0.09 kilogram.
Preparation method: take above-mentioned Chinese crude drug, cleans roguing, dries, be ground into granule, pulverization, by every bag of 100 grams of subpackages.
embodiment 2
Crude drug prescription: Cortex Magnoliae Officinalis 0.23 kilogram, Fructus Gardeniae 0.3 kilogram, the Fructus Sophorae 0.32 kilogram, Rhizoma Zingiberis 0.06 kilogram, Radix Morindae Officinalis 0.08 kilogram.
Preparation method: take above-mentioned Chinese crude drug, cleans roguing, dries, be ground into granule, pulverization, by every bag of 100 grams of subpackages.
embodiment 3
Crude drug prescription: Cortex Magnoliae Officinalis 0.3 kilogram, Fructus Gardeniae 0.21 kilogram, the Fructus Sophorae 0.4 kilogram, Rhizoma Zingiberis 0.1 kilogram, Radix Morindae Officinalis 0.06 kilogram.
Preparation method: take above-mentioned Chinese crude drug, cleans roguing, dries, be ground into granule, pulverization, by every bag of 100 grams of subpackages.
embodiment 4
Crude drug prescription: Cortex Magnoliae Officinalis 0.25 kilogram, Fructus Gardeniae 0.25 kilogram, the Fructus Sophorae 0.45 kilogram, Rhizoma Zingiberis 0.08 kilogram, Radix Morindae Officinalis 0.1 kilogram.
Preparation method: take above-mentioned Chinese crude drug, cleans roguing, dries, be ground into granule, pulverization, by every bag of 100 grams of subpackages.
the clinical trial example of embodiment 5 treatment by Chinese herbs postpartum retention of urine puerpera
There is childbirth puerpera 42 example of postpartum retention of urine, age 21-30 year, 26.1 ± 0.8 years old mean age, pregnant all 37-41 week, in average (38.7 ± 1.1) week, being primipara's row lateral episiotomy produces, the sick and protopathy of foundation-free.All puerperas are divided into matched group (21 example) at random, and test group (21 example), two groups of there was no significant differences in age, pregnant cycle and the state of an illness etc., have comparability.
Two groups of puerpera's routines give to instruct puerperal, and matched group adopts conventional treatment, that is: abdominal massaging, pudendum hot water injection, listen 30min singing of the stream induced uresis.Test group is aided with rapidly herbal fumigation and cleans on above-mentioned processed conventionally basis, and prescription consists of: Cortex Magnoliae Officinalis 26g, Fructus Gardeniae 25g, Fructus Sophorae 38g, Rhizoma Zingiberis 8g, Radix Morindae Officinalis 9g.Fumigation and wash method method: Chinese crude drug prescription is decocted 1.5 hours, remove decocting liquid 2L, the height of falling people foot cleans bedpan, bedpan is that a people one cleans with one, be cooled to about 45 DEG C airtight sitting postures and fumigate lOmin, just urinate completely when 13 routine puerperas fumigate, and then clean 5-10min after non-row person and non-emptying person fumigate and all can urinate completely.Concrete result of the test is in table 1.
Table l matched group compares (example) with test group treatment effect
Claims (4)
1. treat the pharmaceutical composition of postpartum retention of urine for one kind, it is characterized in that: by weight, described pharmaceutical composition is prepared from by following traditional Chinese medicinal material raw materials: Cortex Magnoliae Officinalis 23-30 part, Fructus Gardeniae 21-30 part, Fructus Sophorae 32-45 part, Rhizoma Zingiberis 6-10 part, Radix Morindae Officinalis 6-12 part; Described pharmaceutical composition is herbal fumigation liniment.
2. the pharmaceutical composition for the treatment of postpartum retention of urine according to claim 1, it is characterized in that: by weight, described pharmaceutical composition is prepared from by following traditional Chinese medicinal material raw materials: Cortex Magnoliae Officinalis 25-27 part, Fructus Gardeniae 24-26 part, Fructus Sophorae 36-40 part, Rhizoma Zingiberis 7-9 part, Radix Morindae Officinalis 8-10 part.
3. the pharmaceutical composition for the treatment of postpartum retention of urine according to claim 2, it is characterized in that: by weight, described pharmaceutical composition is prepared from by following traditional Chinese medicinal material raw materials: Cortex Magnoliae Officinalis 26 parts, Fructus Gardeniae 25 parts, the Fructus Sophorae 38 parts, Rhizoma Zingiberis 8 parts, Radix Morindae Officinalis 9 parts.
4. the application of the pharmaceutical composition of claim 1 or the treatment postpartum retention of urine described in 2 or 3 in the external used medicine of preparation treatment puerpera postpartum retention of urine.
Priority Applications (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610043478.1A CN105561269A (en) | 2014-02-28 | 2014-02-28 | Method for preparing traditional Chinese medicine fumigation liniment for treating postpartum uroschesis |
| CN201610043465.4A CN105497858A (en) | 2014-02-28 | 2014-02-28 | Medicine composition for treating postpartum urinary retention |
| CN201610043473.9A CN105497860A (en) | 2014-02-28 | 2014-02-28 | Application of medicine composition to preparation of externally used medicine for treating postpartum urinary retention of parturient women |
| CN201610043469.2A CN105497859A (en) | 2014-02-28 | 2014-02-28 | Medicine composition for treating postpartum urinary retention |
| CN201410070799.1A CN103830697B (en) | 2014-02-28 | 2014-02-28 | A kind of pharmaceutical composition for the treatment of postpartum retention of urine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410070799.1A CN103830697B (en) | 2014-02-28 | 2014-02-28 | A kind of pharmaceutical composition for the treatment of postpartum retention of urine |
Related Child Applications (7)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610043473.9A Division CN105497860A (en) | 2014-02-28 | 2014-02-28 | Application of medicine composition to preparation of externally used medicine for treating postpartum urinary retention of parturient women |
| CN201610043469.2A Division CN105497859A (en) | 2014-02-28 | 2014-02-28 | Medicine composition for treating postpartum urinary retention |
| CN201610043474.3A Division CN105664094A (en) | 2014-02-28 | 2014-02-28 | Application of pharmaceutical composition to preparation of externally-applied medicine for treating postpartum urinary retention |
| CN201610043465.4A Division CN105497858A (en) | 2014-02-28 | 2014-02-28 | Medicine composition for treating postpartum urinary retention |
| CN201610043472.4A Division CN105664093A (en) | 2014-02-28 | 2014-02-28 | Application of pharmaceutical composition to preparation of externally-applied medicine for treating postpartum urinary retention |
| CN201610043478.1A Division CN105561269A (en) | 2014-02-28 | 2014-02-28 | Method for preparing traditional Chinese medicine fumigation liniment for treating postpartum uroschesis |
| CN201610043470.5A Division CN105641656A (en) | 2014-02-28 | 2014-02-28 | Medicine composition for treating postpartum uroschesis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103830697A CN103830697A (en) | 2014-06-04 |
| CN103830697B true CN103830697B (en) | 2016-03-02 |
Family
ID=50794799
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610043465.4A Withdrawn CN105497858A (en) | 2014-02-28 | 2014-02-28 | Medicine composition for treating postpartum urinary retention |
| CN201410070799.1A Active CN103830697B (en) | 2014-02-28 | 2014-02-28 | A kind of pharmaceutical composition for the treatment of postpartum retention of urine |
| CN201610043473.9A Withdrawn CN105497860A (en) | 2014-02-28 | 2014-02-28 | Application of medicine composition to preparation of externally used medicine for treating postpartum urinary retention of parturient women |
| CN201610043478.1A Withdrawn CN105561269A (en) | 2014-02-28 | 2014-02-28 | Method for preparing traditional Chinese medicine fumigation liniment for treating postpartum uroschesis |
| CN201610043469.2A Withdrawn CN105497859A (en) | 2014-02-28 | 2014-02-28 | Medicine composition for treating postpartum urinary retention |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610043465.4A Withdrawn CN105497858A (en) | 2014-02-28 | 2014-02-28 | Medicine composition for treating postpartum urinary retention |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610043473.9A Withdrawn CN105497860A (en) | 2014-02-28 | 2014-02-28 | Application of medicine composition to preparation of externally used medicine for treating postpartum urinary retention of parturient women |
| CN201610043478.1A Withdrawn CN105561269A (en) | 2014-02-28 | 2014-02-28 | Method for preparing traditional Chinese medicine fumigation liniment for treating postpartum uroschesis |
| CN201610043469.2A Withdrawn CN105497859A (en) | 2014-02-28 | 2014-02-28 | Medicine composition for treating postpartum urinary retention |
Country Status (1)
| Country | Link |
|---|---|
| CN (5) | CN105497858A (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104147184B (en) * | 2014-08-28 | 2015-04-01 | 时均燕 | Medicine for nursing of postpartum urinary retention |
| CN104436104A (en) * | 2014-11-07 | 2015-03-25 | 黄萍 | Method for preparing traditional Chinese medicine for treating anuresis |
| CN104474211A (en) * | 2014-12-03 | 2015-04-01 | 祝彩云 | Traditional Chinese medicine lotion for treating postpartum urinary retention |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101152367A (en) * | 2007-09-17 | 2008-04-02 | 尹克山 | Traditional Chinese medicine for treating pregnancy retention of urine |
| CN101623411A (en) * | 2008-07-11 | 2010-01-13 | 北京天科仁祥医药科技有限公司 | Chinese medicament for resisting bacteria and diminishing inflammation, clearing away heat and toxic material, and removing blood stasis and relieving pain |
| CN101637592B (en) * | 2009-07-10 | 2011-07-13 | 李小平 | Diuresis antibiotic pill |
| CN102228603B (en) * | 2011-06-16 | 2012-08-29 | 莫忆鸣 | Chinese medicine for treating retention of urine |
| CN102836225A (en) * | 2011-06-23 | 2012-12-26 | 王东 | Traditional Chinese drug preparation for treating postpartum urine retention |
| CN102552857A (en) * | 2012-02-13 | 2012-07-11 | 李承平 | Capsule for removing blood stasis for promoting tissue regeneration after childbirth |
| CN102847058B (en) * | 2012-04-10 | 2013-10-16 | 于泳 | Pharmaceutical composition for treating urinary retention after caesarean section |
| CN103505643B (en) * | 2012-06-17 | 2015-03-11 | 高霞 | Medicament for treating postpartum urinary retention |
| CN103110766A (en) * | 2013-03-23 | 2013-05-22 | 徐姝一 | Traditional Chinese medical composition for treating postpartum urinary retention |
-
2014
- 2014-02-28 CN CN201610043465.4A patent/CN105497858A/en not_active Withdrawn
- 2014-02-28 CN CN201410070799.1A patent/CN103830697B/en active Active
- 2014-02-28 CN CN201610043473.9A patent/CN105497860A/en not_active Withdrawn
- 2014-02-28 CN CN201610043478.1A patent/CN105561269A/en not_active Withdrawn
- 2014-02-28 CN CN201610043469.2A patent/CN105497859A/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| CN103830697A (en) | 2014-06-04 |
| CN105497859A (en) | 2016-04-20 |
| CN105497860A (en) | 2016-04-20 |
| CN105497858A (en) | 2016-04-20 |
| CN105561269A (en) | 2016-05-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103341064B (en) | Chinese medicine composition for treating urine retention | |
| CN105853877B (en) | Weight-losing pharmaceutical composition, preparation containing same and preparation method thereof | |
| CN105148172A (en) | Traditional Chinese medicine decoction for treating dyspepsia | |
| CN107929629A (en) | One kind prolongs age and consolidates ball and preparation method thereof | |
| CN102008610B (en) | Traditional Chinese medicine composition for curing hyperosteogeny | |
| CN103830697B (en) | A kind of pharmaceutical composition for the treatment of postpartum retention of urine | |
| CN104984191A (en) | Traditional Chinese medicine composition for treating acute lumbar muscle sprain | |
| CN102078435B (en) | Medicinal oil for treating pityriasis rosea and preparation method thereof | |
| CN103285300B (en) | Medicinal composition for treating stress incontinence | |
| CN105641656A (en) | Medicine composition for treating postpartum uroschesis | |
| CN104383158B (en) | A kind of Chinese medicine preparation for treating hip soft tissue's injury pain syndrome | |
| CN103393868A (en) | Electuary for cervical vertebral rehabilitation | |
| CN103285243B (en) | Granules for treating hyperglycemia | |
| CN105664094A (en) | Application of pharmaceutical composition to preparation of externally-applied medicine for treating postpartum urinary retention | |
| CN105664093A (en) | Application of pharmaceutical composition to preparation of externally-applied medicine for treating postpartum urinary retention | |
| CN105106863A (en) | Traditional Chinese medicine for treating hyperostosis | |
| CN105362596A (en) | Traditional Chinese medicine for treating pulmonary emphysema and preparation method thereof | |
| CN104306686A (en) | Externally applied medicine for treating leukoderma | |
| CN104740193A (en) | Traditional Chinese medicine composition for treating neck-shoulder muscle strain syndrome and preparation method of traditional Chinese medicine composition | |
| CN103285301B (en) | Method for preparing umbilicus dressing agent for treating stress incontinence | |
| CN103585518A (en) | Traditional Chinese medicinal preparation for treating lichen urticatus | |
| CN103405554A (en) | Bowel clearing medicine before abdominal operation | |
| CN106492106A (en) | A kind of medicated wine of wind-damp dispelling and preparation method thereof | |
| CN101983698A (en) | Traditional Chinese medicine composition for treating rheumatic heart disease and preparation method thereof | |
| CN107693740A (en) | A kind of yin-nourishing heat-clearing sachet and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| C41 | Transfer of patent application or patent right or utility model | ||
| GR01 | Patent grant | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20160205 Address after: Twenty-seventh, No. 396, Emei Mountain Road, Huangdao District, Shandong City, Qingdao Province, Qingdao 266000, Optics Valley Software Park, second floors Applicant after: QINGDAO HUAZHICAO MEDICAL TECHNOLOGY CO., LTD. Applicant after: Dong Wenju Applicant after: Song Huaihua Address before: 266200, No. seven, 179 village, Wenquan Town, Jimo, Shandong, Qingdao Applicant before: Cui Xinming |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20160623 Address after: Twenty-seventh, No. 396, Emei Mountain Road, Huangdao District, Shandong City, Qingdao Province, Qingdao 266000, Optics Valley Software Park, second floors Patentee after: QINGDAO HUAZHICAO MEDICAL TECHNOLOGY CO., LTD. Address before: Twenty-seventh, No. 396, Emei Mountain Road, Huangdao District, Shandong City, Qingdao Province, Qingdao 266000, Optics Valley Software Park, second floors Patentee before: QINGDAO HUAZHICAO MEDICAL TECHNOLOGY CO., LTD. Patentee before: Dong Wenju Patentee before: Song Huaihua |
|
| CB03 | Change of inventor or designer information | ||
| CB03 | Change of inventor or designer information |
Inventor after: Dong Wenju Inventor after: Han Yanjun Inventor after: Li Jingyun Inventor after: Song Huaihua Inventor after: Yin Zhuolian Inventor after: Wang Shuaiju Inventor after: Sun Xiangxiu Inventor after: Lu Shifen Inventor after: Yan Xiuhui Inventor after: Liu Shimei Inventor after: Gu Ping Inventor before: Dong Wenju Inventor before: Song Huaihua |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20170523 Address after: 226200 No. 46 Industrial Park, Nanyang Town, Nantong, Jiangsu, Qidong Patentee after: Qidong planting valve factory Address before: Twenty-seventh, No. 396, Emei Mountain Road, Huangdao District, Shandong City, Qingdao Province, Qingdao 266000, Optics Valley Software Park, second floors Patentee before: QINGDAO HUAZHICAO MEDICAL TECHNOLOGY CO., LTD. |
|
| TR01 | Transfer of patent right |